UROV - Urovant Sciences (UROV) CEO Keith Katkin on Q3 2018 Results - Earnings Call Transcript
Urovant Sciences (UROV)
Q3 2018 Earnings Conference Call
February 13, 2019, 04:30 PM ET
Company Participants
Christine Ocampo - Chief Accounting Officer
Keith Katkin - CEO
Cornelia Haag-Molkenteller - Chief Medical Officer
Michael McFadden - Chief Commercial Officer
Conference Call Participants
Ritu Baral - Cowen
Edward Marks - JPMorgan
Presentation
Operator
Hello, and welcome to the Urovant Sciences Third Quarter 2018 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later we will conduct a question-and-answer session and instructions will follow at that time. [Operator Instructions] As a reminder, this conference